Ziad Younes Selected Research

Sofosbuvir

1/2019	Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy.
11/2016	Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
1/2016	Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziad Younes Research Topics

Disease

9	Fibrosis (Cirrhosis) 01/2023 - 01/2016
6	Infections 01/2019 - 05/2014
4	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2021
4	Chronic Hepatitis C 01/2019 - 01/2013
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Crohn Disease (Crohn's Disease) 01/2016 - 07/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Pruritus (Itching) 01/2021
1	Cicatrix (Scar) 01/2020
1	Alcoholic Fatty Liver 01/2020
1	Disease Progression 01/2016
1	Body Weight (Weight, Body) 05/2014

Drug/Important Bio-Agent (IBA)

8	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 01/2013
4	selonsertibIBA 01/2023 - 11/2019
4	dasabuvirIBA 01/2019 - 05/2014
4	paritaprevirIBA 01/2019 - 05/2014
4	ombitasvirIBA 01/2019 - 05/2014
4	Ritonavir (Norvir)FDA Link 01/2019 - 05/2014
3	SofosbuvirIBA 01/2019 - 01/2016
3	InterferonsIBA 02/2015 - 01/2013
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2018
2	asunaprevirIBA 12/2014 - 01/2013
1	mRNA VaccinesIBA 12/2021
1	Ad26COVS1IBA 12/2021
1	saroglitazarIBA 12/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	nasIBA 01/2021
1	firsocostatIBA 01/2021
1	aldaferminIBA 01/2021
1	cilofexorIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	BilirubinIBA 01/2021
1	CollagenIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Protons (Proton)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Keratin-18 (Keratin 18)IBA 01/2021
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	ledipasvirIBA 01/2019
1	QuartzIBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2016
1	NucleotidesIBA 11/2016
1	voxilaprevirIBA 11/2016
1	velpatasvirIBA 11/2016
1	Tumor Necrosis Factor InhibitorsIBA 01/2016
1	SimeprevirIBA 01/2016
1	Certolizumab Pegol FDA Link 01/2016
1	apilimodIBA 07/2010
1	Interleukin-12 (IL 12)IBA 07/2010
1	CytokinesIBA 07/2010
1	Interleukin-23 (Interleukin 23)IBA 07/2010

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2016
1	Aftercare (After-Treatment) 02/2015